Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Nu-Med Plus (NUMD) Gains from Investment Securities (2016 - 2021)

Nu-Med Plus' Gains from Investment Securities history spans 6 years, with the latest figure at $40353.0 for Q4 2021.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $40353.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $52287.0, a 123.9% increase, with the full-year FY2021 number at $52000.0, up 335.73% from a year prior.
  • Gains from Investment Securities hit $40353.0 in Q4 2021 for Nu-Med Plus, up from $11934.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for NUMD hit a ceiling of $40353.0 in Q4 2021 and a floor of $11419.0 in Q3 2019.
  • Historically, Gains from Investment Securities has averaged $21235.3 across 3 years, with a median of $11934.0 in 2020.
  • The widest YoY moves for Gains from Investment Securities: up 4.51% in 2020, down 4.51% in 2020.
  • Tracing NUMD's Gains from Investment Securities over 3 years: stood at $11419.0 in 2019, then grew by 4.51% to $11934.0 in 2020, then soared by 238.13% to $40353.0 in 2021.
  • Business Quant data shows Gains from Investment Securities for NUMD at $40353.0 in Q4 2021, $11934.0 in Q3 2020, and $11419.0 in Q3 2019.